Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$32.2M Buy
371,421
+16,147
+5% +$1.33M 0.22% 84
2019
Q3
$28.5M Buy
355,274
+13,906
+4% +$1.11M 0.21% 89
2019
Q2
$27.3M Buy
341,368
+31,168
+10% +$2.39M 0.21% 86
2019
Q1
$24.6M Buy
310,200
+34,387
+12% +$2.57M 0.2% 89
2018
Q4
$20.1M Buy
275,813
+11,561
+4% +$816K 0.2% 91
2018
Q3
$17.9M Buy
264,252
+52,708
+25% +$3.36M 0.18% 99
2018
Q2
$12.3M Sell
211,544
-17,012
-7% -$960K 0.17% 117
2018
Q1
$11.9M Sell
228,556
-3,688
-2% -$199K 0.16% 121
2017
Q4
$12.5M Buy
232,244
+4,144
+2% +$230K 0.17% 115
2017
Q3
$13.9M Buy
228,100
+27,290
+14% +$1.65M 0.22% 91
2017
Q2
$12.3M Buy
200,810
+18,306
+10% +$1.11M 0.22% 102
2017
Q1
$11.1M Sell
182,504
-1,280
-0.7% -$77.7K 0.22% 95
2016
Q4
$10.3M Sell
183,784
-24,393
-12% -$1.43M 0.23% 92
2016
Q3
$12.4M Buy
208,177
+9,781
+5% +$572K 0.3% 70
2016
Q2
$10.9M Buy
+198,396
New +$10.6M 0.29% 72

Other funds holding MRK

Advisor Group's MRK Position: Q4 2019 in Review

Advisor Group increased its Merck (MRK) stake by 4.5% in Q4 2019, buying an estimated $1.33M and bringing the position to 371,421 shares worth $32.2M. The position accounts for 0.22% of the portfolio, ranked #84.

Advisor Group first reported a position in MRK in Q2 2016 and has held it in 15 quarters since. 2,536 funds tracked by Wall St. Rank hold MRK as of Q4 2019.

  • Advisor Group held 371,421 shares of Merck worth $32.2M as of Q4 2019.
  • Advisor Group bought 16,147 Merck shares in Q4 2019, an estimated $1.33M.
  • Merck made up 0.22% of Advisor Group's portfolio in Q4 2019, its #84 holding.
  • Advisor Group first reported a position in Merck in Q2 2016 and has held it in 15 quarters since.
  • 2,536 funds tracked by Wall St. Rank held Merck as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.